Trials / Completed
CompletedNCT05177978
The Cognitive Effects of 6- and 12-weeks Administration of a Food Supplement Containing Phosphatidylserine in Healthy Children Aged 8 to 12 Years
The Chronic Cognitive Effects of 6- and 12-weeks Administration of a Food Supplement Containing Phosphatidylserine: A Double Blind, Randomized, Placebo Controlled, Parallel Groups Study in Healthy Children Aged 8 to 12 Years
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 208 (actual)
- Sponsor
- Northumbria University · Academic / Other
- Sex
- All
- Age
- 8 Years – 12 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the cognitive effects (attention, learning, and memory) of 6 and 12 weeks administration of a supplement containing phosphatidylserine in comparison to a placebo in healthy children aged 8 to 12 years old. The study will utilize Rey Auditory Verbal Learning Test (RAVLT) and Computerised Mental Performance Assessment System (COMPASS, Northumbria University) for a broad assessment of cognitive function/learning, and actigraphy to monitor sleep.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Phosphatidylserine | Phosphatidylserine containing supplement (2 x chewable gummies/day; Total daily dose of 100 mg elemental phosphatidylserine) |
| DIETARY_SUPPLEMENT | Placebo | Placebo comparator (2 x chewable gummies/day, matched to shape and color without active ingredient) |
Timeline
- Start date
- 2020-11-02
- Primary completion
- 2022-08-14
- Completion
- 2022-08-14
- First posted
- 2022-01-05
- Last updated
- 2022-09-28
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05177978. Inclusion in this directory is not an endorsement.